BioXcel Therapeutics, Inc.
11
Thomas M Horan
08/27/2026
09/02/2026
Yes
v
| STANDOrder, PlnDue, DsclsDue, CLMSAGNT, MEGA, SealedDoc(s), SEALEDMATRIX, LEAD |
Assigned to: Bankruptcy Judge Thomas M Horan Chapter 11 Voluntary Asset |
|
Debtor BioXcel Therapeutics, Inc.
555 Long Wharf Drive 12th Floor New Haven, CT 06511 NEW HAVEN-CT Tax ID / EIN: 82-1386754 |
represented by |
Sean Matthew Beach
Young, Conaway, Stargatt & Taylor 1000 North King Street Wilmington, DE 19801 302-571-6600 Fax : 302-576-3281 Email: sbeach@ycst.com Jared W Kochenash
Young Conaway Stargatt & Taylor, LLP Rodney Square 1000 North King Street Wilmington, DE 19801 302-571-6600 Email: jkochenash@ycst.com Jeremiah P. Ledwidge
COOLEY LLP 55 Hudson Yards New York, NY 10001 212-479-6773 Email: jledwidge@cooley.com Michael S. Neumeister
Cooley LLP 350 South Grand Avenue Suite 900 Los Angeles, CA 90071 (213)561-3250 Email: mneumeister@cooley.com Benjamin J. Thomson
COOLEY LLP 110 N. Wacker Drive, Suite 4200 Chicago, IL 60606 312) 881-6396 Email: bthomson@cooley.com Eric E. Walker
Cooley LLP 110 North Wacker Drive Suite 4200 Chicago, IL 60606-1511 312-881-6375 Fax : 312-881-6598 Email: ewalker@cooley.com |
U.S. Trustee U.S. Trustee
Office of the United States Trustee J. Caleb Boggs Federal Building 844 King Street, Suite 2207 Lockbox 35 Wilmington, DE 19801 (302)-573-6491 |
represented by |
Benjamin A. Hackman
Office of the United States Trustee 844 King Street Suite 2207 Wilmington, DE 19801 302-573-6491 Fax : 302-573-6497 Email: benjamin.a.hackman@usdoj.gov |
Claims Agent Stretto
www.stretto.com 410 Exchange, Ste 100 Irvine, CA 92602 855-812-6112 |
| |
Transcriber Reliable Companies
Attn: Gene Matthews 1007 North Orange Street Suite 110 Wilmington, DE 19801 302-654-8080 |
| Date Filed | # | Docket Text |
|---|---|---|
| 09/02/2026 | 78 | Motion to Establish Deadline to File Proofs of Claim // Motion of the Debtors for Entry of an Order (I) Establishing Bar Dates and Related Procedures for Filing Proofs of Claim (Including for Administrative Expense Claims Arising Under Section 503(b)(9) of the Bankruptcy Code); (II) Approving the Form and Manner of Notice Thereof; and (III) Granting Related Relief Filed by BioXcel Therapeutics, Inc.. Hearing scheduled for 9/28/2026 at 02:00 PM at US Bankruptcy Court, 824 Market St., 3rd Fl., Courtroom #7, Wilmington, Delaware. Objections due by 9/16/2026. (Attachments: # 1 Notice # 2 Exhibit A) (Kochenash, Jared) (Entered: 09/02/2026) |
| 09/02/2026 | 77 | Notice of Meeting of Creditors/Commencement of Case Filed by BioXcel Therapeutics, Inc.. 341(a) meeting to be held on 9/30/2026 at 01:00 PM at Virtual Hearing: Refer to Notice of Zoom Hearing. Objection 523 due by 11/30/2026. (Kochenash, Jared) (Entered: 09/02/2026) |
| 09/02/2026 | 76 | Notice to Counsel Regarding Scheduling of 341 Meeting (related document(s)73) (IJW) (Entered: 09/02/2026) |
| 09/02/2026 | 75 | Certification of Counsel Regarding Scheduling of Omnibus Hearing Dates Filed by BioXcel Therapeutics, Inc.. (Kochenash, Jared) (Entered: 09/02/2026) |
| 09/02/2026 | Filed by U.S. Trustee. (Hackman, Benjamin) (Entered: 09/02/2026) | |
| 09/02/2026 | 74 | The upcoming 341(a) meeting is scheduled to be held by Zoom. To join the meeting: Meeting ID: 160 0838 5103 ; Passcode: 4568293370 ; Phone: 1 (669) 254-5252. Filed by U.S. Trustee. (Hackman, Benjamin) (Entered: 09/02/2026) |
| 09/02/2026 | 73 | Request of US Trustee to Schedule Section 341 Meeting of Creditors for Wednesday, September 30, 2026, at 1:00 p.m. (ET) Filed by U.S. Trustee. (Hackman, Benjamin) (Entered: 09/02/2026) |
| 09/01/2026 | 72 | Exhibit(s) - Notice of Equity Transfer Procedures and Procedures for Declarations of Worthlessness (related document(s)12, 63) Filed by BioXcel Therapeutics, Inc.. (Kochenash, Jared) (Entered: 09/01/2026) |
| 09/01/2026 | 71 | Exhibit(s) - Notice of Record Date for Notice and Sell-Down Procedures for Trading in Claims Against the Debtors' Estates (related document(s)12, 63) Filed by BioXcel Therapeutics, Inc.. (Kochenash, Jared) (Entered: 09/01/2026) |
| 08/31/2026 | 70 | (REDACTED) Notice of Filing of List of Equity Security Holders (related document(s)69) Filed by BioXcel Therapeutics, Inc.. (Kochenash, Jared) (Entered: 08/31/2026) |